Percutaneous oestrogen therapy opposed by lynestrenol or natural progesterone - effects on circulating oestrogens, FSH, sex hormone binding globulin and pregnancy zone protein

This publication has 22 references indexed in Scilit:

• Effects on sex hormone binding globulin capacity and pregnancy zone protein of treatment with combinations of ethinyl-oestradiol and norethisterone
  Maturitas, 1981
• A Comparison of Plasma Protein Changes Induced by Danazol, Pregnancy, and Estrogens*
  Journal of Clinical Endocrinology & Metabolism, 1979
• SEX HORMONE BINDING GLOBULIN CAPACITY AS AN INDEX OF OESTROGENICITY OR ANDROGENICITY IN WOMEN ON ORAL CONTRACEPTIVE STEROIDS
  Clinical Endocrinology, 1979
• Conjugated equine oestrogens and blood clotting: a follow-up report.
  BMJ, 1977
• A radioimmunoassay for “the pregnancy zone protein”
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1976
• Surgically Confirmed Gallbladder Disease, Venous Thromboembolism, and Breast Tumors in Relation to Postmenopausal Estrogen Therapy
  New England Journal of Medicine, 1974
• Radioimmunological Methods for the Estimation of Oestrone, Oestradiol 17β and Oestriol in Pregnancy Plasma
  Published by Wiley ,1974
• The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research Group
  Published by American Medical Association (AMA) ,1973
• A new method for the determination of the binding capacity of testosterone-estradiol-binding-globulin in human plasma
  Journal of Steroid Biochemistry, 1973
• Hypertension, Oral Contraceptive Agents, and Conjugated Estrogens
  Annals of Internal Medicine, 1971